Sonoma Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q4 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Sonoma Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q4 2024.
  • Sonoma Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending February 4, 2025 was 1.62M shares, a 89.6% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 1.62M -14M -89.6% Feb 4, 2025 10-Q 2025-02-05
Q3 2024 1.34M -12.3M -90.2% Nov 7, 2024 10-Q 2024-11-07
Q2 2024 18.8M +13.8M +280% Jun 17, 2024 10-K 2024-06-17
Q4 2023 15.6M +11M +236% Feb 7, 2024 10-Q 2024-02-08
Q3 2023 13.7M +10.6M +341% Nov 9, 2023 10-Q 2023-11-13
Q2 2023 4.94M +1.84M +59.4% Jun 16, 2023 10-K 2023-06-21
Q4 2022 4.65M +1.55M +50.1% Feb 10, 2023 10-Q 2023-02-14
Q3 2022 3.1M +5.3K +0.17% Nov 11, 2022 10-Q 2022-11-14
Q2 2022 3.1M +1.01M +48.3% Jul 11, 2022 10-K 2022-07-13
Q4 2021 3.1M +1.02M +49.1% Feb 11, 2022 10-Q 2022-02-11
Q3 2021 3.1M +1.05M +51.6% Nov 12, 2021 10-Q 2021-11-15
Q2 2021 2.09M +122K +6.2% Jul 12, 2021 10-K 2021-07-14
Q4 2020 2.08M +300K +16.9% Feb 11, 2021 10-Q 2021-02-16
Q3 2020 2.04M +713K +53.6% Nov 9, 2020 10-Q/A 2020-11-17
Q2 2020 1.97M +640K +48.2% Jul 7, 2020 10-K 2020-07-10
Q4 2019 1.78M -10.2M -85.2% Feb 12, 2020 10-Q 2020-02-14
Q3 2019 1.33M -5.26M -79.8% Nov 14, 2019 10-Q 2019-11-14
Q2 2019 1.33M -5.09M -79.3% Jun 28, 2019 10-K 2019-07-01
Q4 2018 12M +7.24M +153% Feb 11, 2019 10-Q 2019-02-14
Q3 2018 6.59M +2.27M +52.5% Oct 29, 2018 10-Q 2018-11-08
Q2 2018 6.42M +2.12M +49.3% Jun 21, 2018 10-K 2018-06-26
Q4 2017 4.73M Feb 9, 2018 10-Q 2018-02-14
Q3 2017 4.32M +111K +2.65% Nov 14, 2017 10-Q 2017-11-14
Q2 2017 4.3M -16.7M -79.5% Jun 26, 2017 10-K 2017-06-28
Q1 2017 4.26M Feb 15, 2017 10-Q 2017-02-17
Q3 2016 4.21M -12.2M -74.3% Nov 9, 2016 10-Q 2016-11-15
Q2 2016 21M +5.95M +39.6% Jun 20, 2016 10-K 2016-06-21
Q4 2015 17.2M +2.31M +15.5% Feb 10, 2016 10-Q 2016-02-16
Q3 2015 16.4M +7.76M +89.5% Oct 29, 2015 10-Q 2015-11-10
Q2 2015 15M +6.59M +77.8% Jun 11, 2015 10-K 2015-06-16
Q4 2014 14.9M +7.67M +106% Feb 12, 2015 10-Q 2015-02-12
Q3 2014 8.66M Nov 12, 2014 10-Q 2014-11-13
Q2 2014 8.46M +1.83M +27.7% Jun 23, 2014 10-K 2014-06-30
Q4 2013 7.24M -30.1M -80.6% Jan 31, 2014 10-Q 2014-02-14
Q2 2013 6.63M -25.9M -79.6% Jul 24, 2013 10-Q 2013-08-14
Q4 2012 37.4M +8.51M +29.5% Jan 24, 2013 10-Q 2013-02-13
Q3 2012 37.1M +10.2M +37.9% Nov 2, 2012 10-Q 2012-11-08
Q2 2012 32.6M +5.76M +21.5% Jul 23, 2012 10-Q/A 2012-08-31
Q4 2011 28.9M Jan 27, 2012 10-Q 2012-02-10
Q3 2011 26.9M Nov 3, 2011 10-Q 2011-11-03
Q2 2011 26.8M Aug 4, 2011 10-Q/A 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.